Xencor Inc (XNCR)
19.02
+0.65
(+3.54%)
USD |
NASDAQ |
Apr 24, 16:00
19.04
+0.02
(+0.08%)
After-Hours: 20:00
Xencor Total Liabilities (Quarterly): 283.56M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 283.56M |
| September 30, 2023 | 109.42M |
| June 30, 2023 | 99.24M |
| March 31, 2023 | 119.83M |
| December 31, 2022 | 118.77M |
| September 30, 2022 | 112.57M |
| June 30, 2022 | 108.98M |
| March 31, 2022 | 94.90M |
| December 31, 2021 | 104.71M |
| September 30, 2021 | 78.40M |
| June 30, 2021 | 48.66M |
| March 31, 2021 | 109.12M |
| December 31, 2020 | 130.80M |
| September 30, 2020 | 77.87M |
| June 30, 2020 | 74.08M |
| March 31, 2020 | 73.96M |
| December 31, 2019 | 77.05M |
| September 30, 2019 | 76.01M |
| June 30, 2019 | 76.66M |
| March 31, 2019 | 87.44M |
| December 31, 2018 | 55.05M |
| September 30, 2018 | 53.31M |
| Date | Value |
|---|---|
| June 30, 2018 | 72.28M |
| March 31, 2018 | 74.61M |
| December 31, 2017 | 73.74M |
| September 30, 2017 | 107.72M |
| June 30, 2017 | 114.80M |
| March 31, 2017 | 114.56M |
| December 31, 2016 | 114.61M |
| September 30, 2016 | 119.71M |
| June 30, 2016 | 125.68M |
| March 31, 2016 | 35.15M |
| December 31, 2015 | 44.48M |
| September 30, 2015 | 58.17M |
| June 30, 2015 | 10.50M |
| March 31, 2015 | 9.337M |
| December 31, 2014 | 8.533M |
| September 30, 2014 | 11.16M |
| June 30, 2014 | 10.85M |
| March 31, 2014 | 12.43M |
| December 31, 2013 | 13.78M |
| September 30, 2013 | 15.63M |
| June 30, 2013 | 17.34M |
| December 31, 2012 | 31.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
48.66M
Minimum
Jun 2021
283.56M
Maximum
Dec 2023
103.93M
Average
99.24M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.603B |
| Karyopharm Therapeutics Inc | 376.64M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 952.69M |
| Shareholders Equity (Quarterly) | 668.80M |
| Debt to Equity Ratio | 0.0314 |
| Current Ratio | 7.356 |
| Net Debt Paydown Yield | -0.32% |